Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

brain money alzheimer dementia

Coverage is now available for new Alzheimer's drug

In a July 6 announcement, CMS shared that coverage is officially available for Leqembi for those who meet certain criteria.

July 7, 2023
insurance

President Biden cracks down on short-term health plans, calls them 'junk insurance'

The proposed rule would require that short-term plans are truly short-term and are active for just three months.

July 7, 2023
Researchers examined data from more than 900 patients, presenting their findings in the Journal of the American Heart Association. Money and healthcare spending and econimics.

Cost of healthcare expected to increase by 7% in 2024

The estimated increase is driven by multiple factors, including labor shortages, provider contract negotiations and rising drug prices.

July 5, 2023
update policy

CMS slated to introduce nearly 400 new CPT codes in October

The upcoming changes include a total of 395 new codes, 25 deletions and 13 revisions.

June 30, 2023
Stocks

SEC nails former Pfizer employee for insider trading ahead of COVID drug announcement

The senior statistician purchased short-term stock options, including some that expired the next day, after allegedly being made aware of Paxlovid’s success in clinical trials ahead of a public announcement.

June 30, 2023
Supreme Court

American Medical Association slams Supreme Court ruling on affirmative action, saying it 'undermines decades of progress'

"Diversity is vital to healthcare, and this court ruling deals a serious blow to our goal of increasing medical career opportunities for historically marginalized and minoritized people."

June 29, 2023
The FDA has approved donislecel, a new pancreatic islet cellular therapy made from the pancreatic cells of deceased donors, for the treatment of type 1 diabetes among adult patients with severe hypoglycemia. Lantidra

FDA approves first cellular therapy to treat type 1 diabetes

The new therapy, made from the pancreatic cells of deceased donors, is designed to help adult type 1 diabetes with severe hypoglycemia go a year or longer without needing to take insulin. 

June 29, 2023

Former Johnson & Johnson sales rep indicted for defrauding hospital out of hundreds of thousands of dollars

The sales representative is alleged to have falsely documented his sales numbers on invoices submitted to the hospital’s billing department in addition to interfering with their sterilization processes, according to the DOJ.

June 28, 2023

Around the web

Jeffrey Kuvin, MD, one of the leading voices behind efforts to create a new Board of Cardiovascular Medicine, spoke with Cardiovascular Business about where things stand today.

Half a year after President Biden officially directed federal agencies in the executive branch’s bailiwick to “seize the promise and manage the risks” of AI, the White House has posted a status report.

U.S. physicians often receive payments from medical device manufacturers and pharmaceutical companies. New research in JAMA found a connection between receiving such payments and using specific devices—should the industry be concerned? 

Trimed Popup
Trimed Popup